GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bloomios Inc (OTCPK:BLMS) » Definitions » Piotroski F-Score

Bloomios (Bloomios) Piotroski F-Score : 3 (As of May. 24, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Bloomios Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Bloomios has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Bloomios's Piotroski F-Score or its related term are showing as below:

BLMS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 4
Current: 3

During the past 10 years, the highest Piotroski F-Score of Bloomios was 4. The lowest was 2. And the median was 3.


Bloomios Piotroski F-Score Historical Data

The historical data trend for Bloomios's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomios Piotroski F-Score Chart

Bloomios Annual Data
Trend Jun02 Jun03 Jun04 Jan05 Jan06 Jan07 Jan19 Jan20 Dec21 Dec22
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 N/A N/A N/A N/A

Bloomios Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A 2.00 3.00 3.00

Competitive Comparison of Bloomios's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Bloomios's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bloomios's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bloomios's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Bloomios's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Net Income was -8.549 + -2.735 + -2.292 + -26.033 = $-39.61 Mil.
Cash Flow from Operations was -5.534 + -0.528 + 0.117 + -1.17 = $-7.12 Mil.
Revenue was 2.12 + 2.755 + 2.673 + 0.682 = $8.23 Mil.
Gross Profit was 0.238 + 0.675 + 0.825 + 0.316 = $2.05 Mil.
Average Total Assets from the begining of this year (Sep22)
to the end of this year (Sep23) was
(3.246 + 26.011 + 26.501 + 26.002 + 1.932) / 5 = $16.7384 Mil.
Total Assets at the begining of this year (Sep22) was $3.25 Mil.
Long-Term Debt & Capital Lease Obligation was $0.27 Mil.
Total Current Assets was $0.35 Mil.
Total Current Liabilities was $33.13 Mil.
Net Income was -0.579 + -1.256 + -1.162 + -2.101 = $-5.10 Mil.

Revenue was 1.659 + 1.494 + 1.265 + 1.198 = $5.62 Mil.
Gross Profit was 0.698 + 0.64 + 0.75 + 0.6 = $2.69 Mil.
Average Total Assets from the begining of last year (Sep21)
to the end of last year (Sep22) was
(4.204 + 4.007 + 4.078 + 3.59 + 3.246) / 5 = $3.825 Mil.
Total Assets at the begining of last year (Sep21) was $4.20 Mil.
Long-Term Debt & Capital Lease Obligation was $0.15 Mil.
Total Current Assets was $0.44 Mil.
Total Current Liabilities was $8.05 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Bloomios's current Net Income (TTM) was -39.61. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Bloomios's current Cash Flow from Operations (TTM) was -7.12. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep22)
=-39.609/3.246
=-12.20240296

ROA (Last Year)=Net Income/Total Assets (Sep21)
=-5.098/4.204
=-1.21265461

Bloomios's return on assets of this year was -12.20240296. Bloomios's return on assets of last year was -1.21265461. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Bloomios's current Net Income (TTM) was -39.61. Bloomios's current Cash Flow from Operations (TTM) was -7.12. ==> -7.12 > -39.61 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=0.269/16.7384
=0.01607083

Gearing (Last Year: Sep22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep21 to Sep22
=0.15/3.825
=0.03921569

Bloomios's gearing of this year was 0.01607083. Bloomios's gearing of last year was 0.03921569. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep23)=Total Current Assets/Total Current Liabilities
=0.346/33.128
=0.01044434

Current Ratio (Last Year: Sep22)=Total Current Assets/Total Current Liabilities
=0.443/8.052
=0.05501739

Bloomios's current ratio of this year was 0.01044434. Bloomios's current ratio of last year was 0.05501739. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Bloomios's number of shares in issue this year was 61.473. Bloomios's number of shares in issue last year was 13.2. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2.054/8.23
=0.24957473

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2.688/5.616
=0.47863248

Bloomios's gross margin of this year was 0.24957473. Bloomios's gross margin of last year was 0.47863248. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep22)
=8.23/3.246
=2.53542822

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep21)
=5.616/4.204
=1.3358706

Bloomios's asset turnover of this year was 2.53542822. Bloomios's asset turnover of last year was 1.3358706. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Bloomios has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Bloomios  (OTCPK:BLMS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Bloomios Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Bloomios's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Bloomios (Bloomios) Business Description

Traded in Other Exchanges
N/A
Address
701 Anacapa Street, Suite C, Santa Barbara, CA, USA, 93101
Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.
Executives
Douglas S Rohrer officer: Chief Business Officer 701 ANACAPA, SUITE C, SANTA BARBARA CA 93101
Emc2 Capital Llc 10 percent owner 201 W MONTECITO STREET, SANTA BARBARA CA 93101
Barrett Evans director, 10 percent owner, officer: Pres, Chief Strategy Officer
Aline Hayuta Elkayam 10 percent owner 104 CHELSEA PLACE, ORMOND BEACH FL 32174
Bibi Daprile 10 percent owner 12 WINDING CREEK WAY, ORMOND BEACH FL 32174
Agpl Acquisition, Inc 10 percent owner 201 W MONTECITO ST., SANTA BARBARA CA 93101
Mammoth Crest Capital Llc 10 percent owner 1712 PIONEER AVE, SUITE 558, CHEYENNE WY 82001
Michael Hill director, 10 percent owner, officer: Chief Executive Officer 201 WEST MONTECITO STREET, SANTA BARBARA CA 93101
Bryan Glass director, 10 percent owner, officer: President and Director 20 WEST PARK AVENUE, SUITE 207, LONG BEACH NY 11561
Douglas Boyd director, officer: Chairman of the Board 8101 TIARA COVE CIR, LAS VEGAS NV 89128
Peter A Hogendoorn director, officer: President & CEO 13288 AMBLE GREEN PLACE, SURREY A1 V4A 6P5
Harold C Moll director, 10 percent owner
Van Laare Derek R officer: Secretary 6119 GORDON AVENUE, BURNABY A1 V5E 3M2
Carlo Civelli other: former director/officer/owner 111 SOMERSET ROAD, TRIPLE ONE SOMERSET 06-06, SINGAPORE U0 238164
Logan Anderson director, officer: President & Treasurer 15 HILL CRESCENT, PEMBROKE BERMUDA D8 00000

Bloomios (Bloomios) Headlines

From GuruFocus

Bloomios to Present at the 2022 LD Micro Invitational June 7-9

By PRNewswire PRNewswire 06-14-2022

Bloomios to Present at the 2022 LD Micro Invitational June 7-9

By PRNewswire PRNewswire 06-24-2022

DRYWORLD Struts into Multi-Billion Dollar CBD Market

By GuruFocusNews GuruFocusNews 03-31-2022

Bloomios to Present at the 2022 LD Micro Invitational June 7-9

By PRNewswire PRNewswire 07-14-2022

Bloomios Appoints Kevin Henry as National Sales Director

By PRNewswire PRNewswire 06-09-2023

Bloomios Shareholder Update & Growth Strategy

By PRNewswire PRNewswire 11-17-2021

Bloomios to Present at the 2022 LD Micro Invitational June 7-9

By PRNewswire PRNewswire 07-04-2022

Bloomios to Present at the 2022 LD Micro Invitational June 7-9

By PRNewswire PRNewswire 06-04-2022